Microbio Co., Ltd. (TPEX:4128)

Microbio Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,939	1,894	1,723	1,591	1,722	1,782
Revenue Growth	9.76%	9.94%	8.26%	-7.58%	-3.38%	11.28%
Gross Profit Gross Profit Growth	773.55	753.46	676.08	603.88	691.3	739.37
Operating Income Operating Income Growth	-440.65	-407.11	-451.42	-506.47	-110.31	-1,163
Net Income Net Income Growth	-691.94	-757.75	-1,101	-1,180	211.2	49.42
Earnings Per Share EPS Growth	-1.18	-1.29	-1.87	-2.01	0.36	0.09
EPS Growth	-	-	-	-	316.73%	-92.89%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Health and vitality food Health and vitality food Growth	1,814	1,777	1,638	1,522	1,660	1,724
Research and development of new medicine Research and development of new medicine Growth	125.72	116.95	85.08	69.13	61.63	57.82
Total Total Growth	1,939	1,894	1,723	1,591	1,722	1,782

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	2,814	2,630	2,552	3,637	4,078	4,032
Total Debt Total Debt Growth	645.68	667.2	615.73	619.16	487.82	517.57
Net Cash (Debt) Net Cash Growth	2,168	1,963	1,937	3,018	3,590	3,515
Net Cash Growth	3.38%	1.35%	-35.82%	-15.95%	2.16%	-4.17%
Net Cash Per Share Net Cash Per Share Growth	3.69	3.34	3.29	5.13	6.11	6.13

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	168.77	85.27	529.9	-118.75	141.57	53.98
Capital Expenditures CapEx Growth	-42.85	-60.79	-22.58	-44.78	-38.88	-87.22
Free Cash Flow Free Cash Flow Growth	125.92	24.49	507.32	-163.53	102.69	-33.24
Free Cash Flow Growth	-81.84%	-95.17%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	39.89%	39.78%	39.24%	37.95%	40.15%	41.49%
Operating Margin	-22.72%	-21.49%	-26.20%	-31.83%	-6.41%	-65.25%
Pretax Margin	-47.76%	-50.24%	-74.20%	-86.58%	8.82%	-13.01%
Profit Margin	-35.68%	-40.01%	-63.89%	-74.14%	12.27%	2.77%
FCF Margin	6.49%	1.29%	29.45%	-10.28%	5.96%	-1.86%

Dividends

Chart

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.035	0.032
Dividend Per Share Growth	9.43%	-
Dividend Yield	0.06%	0.06%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	-	-	-	150.52	641.61
Forward PE	-	59.46	59.46	59.46	59.46	59.46
P/FCF Ratio	65.63	444.40	38.26	-	309.59	-
PS Ratio	4.26	5.75	11.27	17.78	18.46	17.79

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error